In the News: Goldman Sachs-CSRC Settlement; First Sci-Tech Board Funds Approved; and Drug Administration Law Under Review

April 29, 2019 | BY

Marilyn Romero

The CSRC has agreed its first administrative settlement with Goldman Sachs and Gao Hua Securities; seven themed funds were approved for Shanghai's new Sci-Tech Board; and the National People's Congress is reviewing measures to tighten up the production and sale of drugs.

Share:

Goldman Sachs

CSRC agrees first administrative settlement with Goldman Sachs

The China Securities Regulatory Commission, or CSRC, has agreed to settle an internal control case against U.S. investment bank Goldman Sachs and